| Jul 31 |
Those who invested in Supernus Pharmaceuticals (NASDAQ:SUPN) three years ago are up 13%
|
| Jul 23 |
Supernus Pharmaceuticals to Announce Second Quarter 2024 Financial Results and Host Conference Call on August 6, 2024
|
| Jul 19 |
If You Can Only Buy One Biotech Stock in July, It Better Be One of These 3 Names
|
| Jul 2 |
Supernus Pharmaceuticals: So-So Neuroscience Portfolio, With ADHD Standout
|
| May 30 |
Supernus Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference
|
| May 24 |
Do Options Traders Know Something About Supernus (SUPN) Stock We Don't?
|
| May 23 |
Supernus Announces Promising Interim Data from Ongoing Open-Label Phase 2a Study of SPN-817 in Epilepsy
|
